A Study to Compare Two Bioanalytical Assays for Tebipenem
Status:
Not yet recruiting
Trial end date:
2023-06-01
Target enrollment:
Participant gender:
Summary
The primary purpose of the study is to compare the concentrations of tebipenem (TBP), the
active moiety of tebipenem pivoxil hydrobromide (TBP-PI-HBr), as determined by two
bioanalytical assays, a whole blood assay and a plasma assay, following a single oral dose of
TBP-PI-HBr 600 milligram (mg) tablets in healthy adult participants.